France vs Panama: Statin use vs. average non-HDL cholesterol levels
France
3.7
in 2018
Panama
3.7
in 2018
France rank
12th
Panama rank
12th
Statin use vs. average non-HDL cholesterol levels over time
- France
- Panama
How they compare
France currently reports 3.7 against 3.7 in Panama, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was France ahead.
France ranks 12th and Panama ranks 12th of 191 countries.
Across the 4 decades both report, France averaged higher in 3 and Panama in 1.
Head to head by decade
| Decade | France | Panama | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 4.36 | 3.65 | 0.71 | France |
| 1990s | 4.13 | 3.75 | 0.38 | France |
| 2000s | 3.89 | 3.8 | 0.09 | France |
| 2010s | 3.74 | 3.77 | 0.0222 | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, France or Panama?
- France, at 3.7 against 3.7 in Panama as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between France and Panama?
- 0, with France ahead.
- How many years of comparable data are there for France and Panama?
- 39 years are reported by both, from 1980 to 2018.
- How do France and Panama rank globally for statin use vs. average non-hdl cholesterol levels?
- France ranks 12th and Panama ranks 12th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.